Skip to main content

538 (Potassium Citrate Extended-Release 15 mEq (1620 mg))

Pill with imprint 538 is Yellow, Elliptical/Oval and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg). It is supplied by Zydus Pharmaceuticals (USA) Inc.

Potassium citrate is used in the treatment of nephrolithiasis; renal tubular acidosis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for 538

Potassium citrate extended-release 15 mEq (1620 mg) 538

Potassium Citrate Extended-Release

Imprint
538
Strength
15 mEq (1620 mg)
Color
Yellow
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Urinary pH modifiers
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
National Drug Code (NDC)
68382-0538
Inactive Ingredients
carnauba wax, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "538"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.